Printer Friendly

CYGNUS AND PROCTER & GAMBLE SIGN AGREEMENT

 REDWOOD CITY, Calif., Oct. 25 /PRNewswire/ -- Cygnus Therapeutic Systems (NASDAQ: CYGN), a leader in the development of advanced drug delivery systems, and Procter & Gamble (NYSE: PG) announced the signing of an agreement for the development and marketing of a new product using one of Cygnus' delivery systems for a potentially significant consumer market. Under terms of the agreement, Procter & Gamble has exclusive worldwide marketing rights to the product, which Cygnus will manufacture and supply.
 "We're delighted to be working with P&G," stated Cygnus President and Chief Executive Officer Gregory Lawless. "Through leveraging our fundamental drug delivery technology which historically was used for prescription drugs, we can add real value to consumer products.
 "P&G was attracted to Cygnus because of their strong technology and the broad range of possible applications for their delivery systems," said Tom Moore, president of P&G's health care business. "In fact, we are in discussions with Cygnus regarding several other delivery systems for a variety of markets."
 Cygnus Therapeutic Systems has focused its range of drug delivery systems on four markets: hormone replacement, glucose monitoring, smoking cessation and consumer products. The company has more than a dozen products in various stages of development, two of which are in phase III clinical trials. In addition to Procter & Gamble, Cygnus' other partners include Warner Lambert, Kabi Pharmacia, Sanofi and Anaquest.
 With nearly $3 billion in worldwide health care sales, Procter & Gamble is one of the fastest-growing health care companies in the United States. P&G makes and markets both prescription and non-prescription products in 60 countries. In recent years, P&G has partnered with a range of leading pharmaceutical and biotechnology companies to co- develop and co-promote innovative new therapies.
 -0- 10/25/93
 /CONTACT: Craig Carlson of Cygnus, 415-369-4300; or Kristin Burbank of P&G, 513-945-8066/
 (PG CYGN)


CO: Cygnus Therapeutic Systems Inc.; Procter & Gamble ST: California, Ohio IN: MTC HOU SU:

LW-TM -- SJ004 -- 6508 10/25/93 16:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 25, 1993
Words:326
Previous Article:FLIR SYSTEMS INC.: FSI ADVANTAGE SERIES PRISM CAMERA SELECTED BY CSI FOR ADVANCED THERMAL IMAGING APPLICATIONS
Next Article:TANGER FACTORY OUTLET CENTERS, INC. REPORTS OPERATING RESULTS FOR THE THIRD QUARTER
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters